GLSI
Greenwich Lifesciences Inc
15.10$
-1.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | – | – | +0.0% | +0.0% | – | – | -3.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -89.1% | +1,432.9% | -85.3% | -9.1% | -42.1% | +0.6% | +4.8% | +279.0% | -52.9% | +97.4% | +18.1% | +214.1% | -19.5% | -61.9% | +172.2% | +42.6% | -25.6% | -24.5% | +56.4% | +8.1% | -5.9% | +5.2% | -0.7% | +168.7% | -63.1% | +54.5% | +0.4% | +115.5% | -31.4% | -31.7% | – | |
| – | – | +2,881.9% | -92.3% | +51.2% | +21.7% | -37.1% | +65.8% | +459.5% | -42.4% | -38.2% | +6.4% | +49.5% | +4.8% | -57.3% | +370.9% | -33.8% | -5.4% | -10.9% | -6.4% | +45.9% | -31.9% | +3.2% | +23.6% | +340.8% | -64.6% | -21.0% | +21.4% | -45.6% | +45.9% | -10.7% | – | |
| – | -90.5% | +1,660.9% | -87.1% | +0.2% | -27.4% | -14.0% | +22.2% | +349.7% | -47.9% | +25.5% | +15.0% | +174.5% | -16.3% | -61.2% | +208.4% | +21.5% | -22.6% | -22.0% | +43.2% | +13.3% | -10.6% | +4.9% | +2.5% | +196.3% | -65.8% | +46.1% | +3.2% | +90.3% | -27.9% | -29.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +39.1% | +135.1% | +135.8% | -23.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.